PULSION Medical Systems SE (PUS) - Total Assets
Based on the latest financial reports, PULSION Medical Systems SE (PUS) holds total assets worth €35.15 Million EUR (≈ $41.09 Million USD) as of December 2017. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check PULSION Medical Systems SE (PUS) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
PULSION Medical Systems SE - Total Assets Trend (2000–2024)
This chart illustrates how PULSION Medical Systems SE's total assets have evolved over time, based on quarterly financial data. Explore PUS strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
PULSION Medical Systems SE - Asset Composition Analysis
Current Asset Composition (December 2024)
PULSION Medical Systems SE's total assets of €35.15 Million consist of 66.9% current assets and 33.1% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0.0% |
| Accounts Receivable | €324.93K | 0.8% |
| Inventory | €4.61 Million | 11.6% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €12.35 Million | 30.9% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2000–2024)
This chart illustrates how PULSION Medical Systems SE's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see PUS market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: PULSION Medical Systems SE's current assets represent 66.9% of total assets in 2024, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2024, down from 26.0% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 30.0% of total assets, an increase from 0.0% in 2000.
- Asset Diversification: The largest asset category is intangible assets at 30.9% of total assets.
PULSION Medical Systems SE Competitors by Total Assets
Key competitors of PULSION Medical Systems SE based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $90.55 Million |
|
Medacta Group SA
SW:MOVE
|
Switzerland | CHF860.76 Million |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
Xiangyu Medical Co. Ltd. A
SHG:688626
|
China | CN¥3.27 Billion |
|
INKON Life Technology Co Ltd
SHE:300143
|
China | CN¥4.17 Billion |
PULSION Medical Systems SE - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.28 | 1.89 | 1.89 |
| Quick Ratio | 2.12 | 1.05 | 1.05 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €12.13 Million | €7.44 Million | €7.44 Million |
PULSION Medical Systems SE - Advanced Valuation Insights
This section examines the relationship between PULSION Medical Systems SE's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.42 |
| Latest Market Cap to Assets Ratio | 4.46 |
| Asset Growth Rate (YoY) | 18.9% |
| Total Assets | €39.93 Million |
| Market Capitalization | $178.09 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values PULSION Medical Systems SE's assets at a significant premium (4.46x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: PULSION Medical Systems SE's assets grew by 18.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for PULSION Medical Systems SE (2000–2024)
The table below shows the annual total assets of PULSION Medical Systems SE from 2000 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €39.93 Million ≈ $46.68 Million |
+18.85% |
| 2023-12-31 | €33.59 Million ≈ $39.28 Million |
-0.97% |
| 2022-12-31 | €33.92 Million ≈ $39.66 Million |
+8.08% |
| 2021-12-31 | €31.39 Million ≈ $36.69 Million |
-7.82% |
| 2020-12-31 | €34.05 Million ≈ $39.81 Million |
+10.49% |
| 2019-12-31 | €30.82 Million ≈ $36.03 Million |
-11.10% |
| 2018-12-31 | €34.66 Million ≈ $40.53 Million |
-1.37% |
| 2017-12-31 | €35.14 Million ≈ $41.09 Million |
+0.21% |
| 2016-12-31 | €35.07 Million ≈ $41.00 Million |
-46.80% |
| 2015-12-31 | €65.92 Million ≈ $77.07 Million |
+151.98% |
| 2013-12-31 | €26.16 Million ≈ $30.58 Million |
-18.76% |
| 2012-12-31 | €32.20 Million ≈ $37.65 Million |
+8.37% |
| 2011-12-31 | €29.71 Million ≈ $34.74 Million |
+15.47% |
| 2010-12-31 | €25.73 Million ≈ $30.09 Million |
-0.05% |
| 2009-12-31 | €25.75 Million ≈ $30.10 Million |
+7.96% |
| 2008-12-31 | €23.85 Million ≈ $27.88 Million |
-11.12% |
| 2007-12-31 | €26.83 Million ≈ $31.37 Million |
+18.04% |
| 2006-12-31 | €22.73 Million ≈ $26.58 Million |
+14.93% |
| 2005-12-31 | €19.78 Million ≈ $23.12 Million |
+13.22% |
| 2004-12-31 | €17.47 Million ≈ $20.42 Million |
+5.92% |
| 2003-12-31 | €16.49 Million ≈ $19.28 Million |
-15.29% |
| 2002-12-31 | €19.47 Million ≈ $22.76 Million |
-6.35% |
| 2001-12-31 | €20.79 Million ≈ $24.31 Million |
+73.74% |
| 2000-12-31 | €11.97 Million ≈ $13.99 Million |
-- |
About PULSION Medical Systems SE
PULSION Medical Systems SE engages in the development, production, and distribution of monitoring, diagnostic, and therapy control systems for recording physiological parameters of hospitalized, seriously ill, and intensive care patients. Its technologies include the PiCCO2 platform, a system used in intensive care medicine for the treatment of critically ill patients; PulsioFlex, which offers te… Read more